Concepedia

Yanlin Yu

YY

Statistics

Publications

22

Citations

2K

H-Index

17

Active since

1992

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Center for Cancer Research

Southern Medical University

Nanfang Hospital

Yanlin Yu is an author at National Cancer Institute specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1992–2024

22

Publications

22

Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators

Yanlin Yu, Javed Khan, Chand Khanna et al. · Nature Medicine · 2004 · 535 citations

, , +9

Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models

James G. Taylor, Adam Cheuk, Patricia Tsang et al. · Journal of Clinical Investigation · 2009 · 322 citations · Full text

, , +17

Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: potentiation and binding to type IV collagen.

Vishwas Paralkar, Benjamin S. Weeks, Yanlin Yu et al. · The Journal of Cell Biology · 1992 · 160 citations · Full text

, , +17

Natural bovine osteogenin and recombinant human bone morphogenetic protein-2B are equipotent in the maintenance of proteoglycans in bovine articular cartilage explant cultures.

Frank P. Luyten, Yanlin Yu, Masaki Yanagishita et al. · Journal of Biological Chemistry · 1992 · 159 citations · Full text

, , +16

Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis

Richard Sharp, Juan A. Recio, Chamelli Jhappan et al. · Nature Medicine · 2002 · 157 citations

, , +14

1–5 of 22